Dartmouth-Hitchcock Medical Center (lead sponsor), 2020-03-02: Registry record for a planned single-centre Phase 2 pilot of methylene blue versus hydroxocobalamin in patients at risk of vasoplegia during cardiac surgery; the study was withdrawn with the stated reason 'Lack of funding'.
Lack of funding
Dartmouth-Hitchcock Medical Center (lead sponsor), 2020-03-02: Registry record for a planned single-centre Phase 2 pilot of methylene blue versus hydroxocobalamin in patients at risk of vasoplegia during cardiac surgery; the study was withdrawn with the stated reason 'Lack of funding'. C4 funding. Lead sponsor Dartmouth-Hitchcock Medical Center (class OTHER, academic); responsible party Ying H. Low, principal investigator; no industry sponsor or collaborator listed. Status WITHDRAWN, whyStopped 'Lack of funding', enrollment 0 actual, estimated start 2019-11; last update posted 2020-03-02. No results posted. Record fields transcribed from the registry JSON (briefTitle / design / sponsor / status fields) – not prose. The human /study/ page is JavaScript-rendered, so the machine-readable api/v2 record is cited so the field is checkable. text_file=B_12.txt
